Cogent Biosciences Inc (COGT)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $4.97B
Last updated: Nov 17, 2026 at 11:05 AM ET
Cogent Biosciences Inc (COGT) Competitors
The companies most similar to Cogent Biosciences are Legend Biotech (LEGN), CG Oncology, Inc. Common stock (CGON) and Crispr Therapeutics AG (CRSP). By market cap, Cogent Biosciences ranks 7th of the 13 companies on this page; Praxis Precision Medicines (PRAX) is the largest at $9.17B.
Peer Comparison
COGT's ROIC of -43.4% is below the peer median of -25.2%, and its revenue growth of -100.0% is below the median of 0.0%. Like the median peer, it pays no dividend.
| Company | Market cap | P/E | P/S | Net margin | ROIC | Rev growth | Div yield |
|---|---|---|---|---|---|---|---|
| Cogent Biosciences (COGT) | $4.97B | N/A | N/A | 0.0% | -43.4% | -100.0% | 0.00% |
| Legend Biotech Corp (LEGN) | $3.39B | 266.5x | 2.3x | -0.0% | N/A | 32.0% | 0.00% |
| CG Oncology, Inc. Common stock (CGON) | $6.65B | N/A | N/A | 0.0% | -21.1% | -3.7% | 0.00% |
| Crispr Therapeutics AG (CRSP) | $4.10B | N/A | 155.2x | 0.0% | -20.3% | 1325.0% | 0.00% |
| Beam Therapeutics Inc (BEAM) | $2.36B | N/A | 15.0x | -73.9% | -29.7% | -96.8% | 0.00% |
| PTC Therapeutics Inc (PTCT) | $5.30B | N/A | 5.2x | -9.2% | 18.1% | 69.6% | 0.00% |
| Celcuity LLC (CELC) | $3.15B | N/A | N/A | 0.0% | -25.2% | 0.0% | 0.00% |
| Cytokinetics Inc (CYTK) | $7.82B | N/A | 65.3x | 0.0% | -66.0% | 2357.0% | 0.00% |
| Viridian Therapeutics Inc (VRDN) | $3.51B | N/A | 128.5x | 0.0% | -41.8% | -63.5% | 0.00% |
| Edgewise Therapeutics Inc (EWTX) | $5.03B | N/A | N/A | 0.0% | N/A | 0.0% | 0.00% |
| Disc Medicine Inc. (IRON) | $3.64B | N/A | N/A | 0.0% | -40.0% | 0.0% | 0.00% |
| Praxis Precision Medicines Inc (PRAX) | $9.17B | N/A | N/A | 0.0% | N/A | 1349.0% | 0.00% |
| Ligand Pharmaceuticals Incorporated (LGND) | $6.18B | 66.5x | 23.7x | 20.3% | 0.1% | -31.8% | 0.00% |
| Peer median | $4.56B | 166.5x | 23.7x | 0.0% | -25.2% | 0.0% | 0.00% |
Similar Companies
These are the 12 companies most similar to Cogent Biosciences, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.
| Company | About | Peers |
|---|---|---|
| Legend Biotech Corp (LEGN) | Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology... | LEGN competitors |
| CG Oncology, Inc. Common stock (CGON) | CG Oncology, Inc. is a clinical-stage biotechnology firm focused on developing groundbreaking cancer therapies, particularly through its lead product, CG0070... | CGON competitors |
| Crispr Therapeutics AG (CRSP) | CRISPR Therapeutics AG, a gene editing company, focuses on the development of gene-based transformative drugs for serious human diseases. | CRSP competitors |
| Beam Therapeutics Inc (BEAM) | Beam Therapeutics Inc., a biotechnology company, develops precision genetic drugs for patients with serious illnesses in the United States. | BEAM competitors |
| PTC Therapeutics Inc (PTCT) | PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for patients with rare disorders. | PTCT competitors |
| Celcuity LLC (CELC) | Celcuity Inc., a clinical-stage biotechnology company, discovers cancer subtypes and therapeutic options for cancer patients in the United States. | CELC competitors |
| Cytokinetics Inc (CYTK) | Cytokinetics, Incorporated, an advanced stage biopharmaceutical company, focuses on discovering... | CYTK competitors |
| Viridian Therapeutics Inc (VRDN) | Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients with serious illnesses. | VRDN competitors |
| Edgewise Therapeutics Inc (EWTX) | Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. | EWTX competitors |
| Disc Medicine Inc. (IRON) | Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development... | IRON competitors |
| Praxis Precision Medicines Inc (PRAX) | Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal... | PRAX competitors |
| Ligand Pharmaceuticals Incorporated (LGND) | Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies discover... | LGND competitors |
Frequently Asked Questions About COGT
Who are Cogent Biosciences' main competitors?
The companies most similar to Cogent Biosciences include Legend Biotech (LEGN), CG Oncology, Inc. Common stock (CGON), Crispr Therapeutics AG (CRSP), Beam Therapeutics (BEAM) and PTC Therapeutics (PTCT), listed from the closest match.
Who is Cogent Biosciences' biggest competitor?
Praxis Precision Medicines (PRAX) is the largest of the similar companies at $9.17B; Legend Biotech (LEGN) is the closest match by business profile, size, sector and industry.
How does COGT stock compare with its competitors?
COGT's net margin is 0.0% against a peer median of 0.0%.
Which of Cogent Biosciences' competitors pays a higher dividend?
Cogent Biosciences pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.
Is Cogent Biosciences bigger than its competitors?
No. Cogent Biosciences is 7th by market cap among the 13 companies on this page; the largest is Praxis Precision Medicines (PRAX) at $9.17B.
COGT pages: Overview, Earnings, Forecast, Financials, Competitors